Atlas Capital Advisors LLC Bristol Myers Squibb CO Transaction History

Atlas Capital Advisors LLC

$788 Billion
Q4 2024

A detailed history of Atlas Capital Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 18,785 shares of BMY stock, worth $1.11 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

18,785

Previous 3,200 487.03%

Holding current value

$1.11 Million

Previous $166 Million 541.72%

% of portfolio

0.13%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$51.92 - $59.94 $809,173 - $934,164	15,585 Added 487.03%	18,785 $1.06 Billion
Q3 2024 Nov 05, 2024	SELL	$39.66 - $51.75 $63,455 - $82,800	-1,600 Reduced 33.33%	3,200 $166 Million
Q2 2024 Jul 29, 2024	BUY	$40.25 - $52.99 $56,752 - $74,715	1,410 Added 41.59%	4,800 $199 Million
Q1 2024 Apr 15, 2024	SELL	$47.98 - $54.4 $67,651 - $76,704	-1,410 Reduced 29.38%	3,390 $184 Million
Q4 2023 Feb 15, 2024	SELL	$48.48 - $57.85 $45,474 - $54,263	-938 Reduced 16.35%	4,800 $246 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $28,829 - $32,235	-498 Reduced 7.99%	5,738 $333 Million
Q2 2023 Aug 15, 2023	SELL	$63.71 - $70.74 $64,028 - $71,093	-1,005 Reduced 13.88%	6,236 $399 Million
Q1 2023 May 16, 2023	SELL	$65.71 - $74.53 $38,111 - $43,227	-580 Reduced 7.42%	7,241 $502 Million
Q4 2022 Feb 15, 2023	BUY	$68.48 - $81.09 $8,491 - $10,055	124 Added 1.61%	7,821 $563 Million
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $156 - $92,208	-1,200 Reduced 13.49%	7,697 $547 Million
Q2 2022 Aug 16, 2022	BUY	$72.62 - $79.98 $133,548 - $147,083	1,839 Added 26.06%	8,897 $685 Million
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $4,180 - $5,012	-68 Reduced 0.95%	7,058 $515 Million
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $200,308 - $233,512	-3,735 Reduced 34.39%	7,126 $444 Million
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $56,862 - $66,606	-961 Reduced 8.13%	10,861 $642,000
Q2 2021 Jul 30, 2021	BUY	$61.91 - $67.42 $44,946 - $48,946	726 Added 6.54%	11,822 $789,000
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $559,160 - $628,891	-9,423 Reduced 45.92%	11,096 $700,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $525,029 - $594,954	-9,093 Reduced 30.71%	20,519 $1.27 Million
Q3 2020 Oct 23, 2020	SELL	$57.43 - $63.64 $88,499 - $98,069	-1,541 Reduced 4.95%	29,612 $1.79 Million
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $124,222 - $145,227	2,266 Added 7.84%	31,153 $1.83 Million
Q1 2020 May 04, 2020	BUY	$46.4 - $67.43 $967,254 - $1.41 Million	20,846 Added 259.25%	28,887 $1.61 Million
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $90,644 - $118,237	1,842 Added 29.71%	8,041 $516,000
Q3 2019 Nov 01, 2019	SELL	$42.77 - $50.71 $27,586 - $32,707	-645 Reduced 9.42%	6,199 $314,000
Q2 2019 Jul 25, 2019	BUY	$44.62 - $49.34 $305,379 - $337,682	6,844 New	6,844 $0
Q1 2019 Apr 29, 2019	SELL	$45.12 - $53.8 $60,054 - $71,607	-1,331 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$50.53 - $62.98 $67,255 - $83,826	1,331 New	1,331 $0

Others Institutions Holding BMY

# of Institutions

2,763

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Bristol Myers Squibb CO Transaction History